OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The gut–liver axis in immune remodeling of hepatic cirrhosis
Huayu Guan, Xiang Zhang, Ming Kuang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24

Showing 24 citing articles:

Global trend in exosome isolation and application: an update concept in management of diseases
Mohammadhassan Omrani, Hanieh Beyrampour-Basmenj, Rana Jahanban‐Esfahlan, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 3, pp. 679-691
Open Access | Times Cited: 42

Polyethylene microplastics induced gut microbiota dysbiosis leading to liver injury via the TLR2/NF-κB/NLRP3 pathway in mice
Ran Xu, Jing-wen Cao, Hongli Lv, et al.
The Science of The Total Environment (2024) Vol. 917, pp. 170518-170518
Closed Access | Times Cited: 31

The Gut–Organ Axis within the Human Body: Gut Dysbiosis and the Role of Prebiotics
Georgia Saxami, Evangelia N. Kerezoudi, Christos Eliopoulos, et al.
Life (2023) Vol. 13, Iss. 10, pp. 2023-2023
Open Access | Times Cited: 26

Immune Checkpoints and the Immunology of Liver Fibrosis
Ioannis Tsomidis, Argyro Voumvouraki, Elias Kouroumalis
Livers (2025) Vol. 5, Iss. 1, pp. 5-5
Open Access

Dysbiosis and extraintestinal cancers
Rui He, Ping-Qian Qi, Lin-Zhen Shu, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access

NSUN2/ALYREF axis-driven m5C methylation enhances PD-L1 expression and facilitates immune evasion in non-small-cell lung cancer
Yiran Yang, Leiqun Cao, Xin Xu, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 4
Open Access

Common microbial signatures in blood and their amplification in clinical disorders
Gwoncheol Park, Suji Oh, Minjeong Kim, et al.
Gut Microbes Reports (2025) Vol. 2, Iss. 1, pp. 1-19
Open Access

The Role of the Gut Microbiome in the Development of Acute Pancreatitis
Ruilin Zhou, Qingyang Wu, Zihan Yang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1159-1159
Open Access | Times Cited: 4

Regulatory mechanisms of the probiotic-targeted gut–liver axis for the alleviation of alcohol-related liver disease: a review
Feiyu Yang, Xiangfei Li, Jing Sun, et al.
Critical Reviews in Food Science and Nutrition (2025), pp. 1-22
Closed Access

Gut Microbiota and Sinusoidal Vasoregulation in MASLD: A Portal Perspective
György Baffy, Piero Portincasa
Metabolites (2024) Vol. 14, Iss. 6, pp. 324-324
Open Access | Times Cited: 3

Caloric restriction mimetics improve gut microbiota: a promising neurotherapeutics approach for managing age-related neurodegenerative disorders
Ishika Singh, Shashi Anand, Deepashree J. Gowda, et al.
Biogerontology (2024) Vol. 25, Iss. 6, pp. 899-922
Open Access | Times Cited: 3

Endotoxin Inflammatory Action on Cells by Dysregulated-Immunological-Barrier-Linked ROS-Apoptosis Mechanisms in Gut–Liver Axis
Andrei Dumitru, Elena Matei, Georgeta Camelia Cozaru, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2472-2472
Open Access | Times Cited: 3

Cuproptosis and its application in different cancers: an overview
Lingyun Xu, Kexin Liu, Feng Wang, et al.
Molecular and Cellular Biochemistry (2023) Vol. 478, Iss. 12, pp. 2683-2693
Closed Access | Times Cited: 8

The Impact of Liver Failure on the Immune System
Alicja Dąbrowska, Bartosz Wilczyński, Jakub Mastalerz, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9522-9522
Open Access | Times Cited: 2

The Potential Mechanism of the Anti-Liver Fibrotic Effect of Curcumin in the Gut-Liver Axis
Qiao Geng, Yanyan Xu, Weifang Huang, et al.
Journal of Medicinal Food (2024) Vol. 27, Iss. 5, pp. 404-418
Closed Access | Times Cited: 1

Potential mechanisms of traditional Chinese medicine in the treatment of liver cirrhosis: a focus on gut microbiota
Siyuan Sun, Guangheng Zhang, Shimeng Lv, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 1

Prediction of prognosis and immune response in lung adenocarcinoma based on mitophagy and lactate-related gene signatures
Wenjie Jiang, Fan Zhang, Zhen Tang, et al.
International Journal of Clinical Oncology (2024) Vol. 30, Iss. 2, pp. 277-297
Closed Access | Times Cited: 1

Selected Aspects of the Intricate Background of Immune-Related Cholangiopathies—A Critical Overview
Beata Kasztelan‐Szczerbińska, Anna Rycyk-Bojarzynska, Agnieszka Szczerbińska, et al.
Nutrients (2023) Vol. 15, Iss. 3, pp. 760-760
Open Access | Times Cited: 3

Enhancing CAR T cells function: role of immunomodulators in cancer immunotherapy
M. Hassaan Rehman, Ariba Qaiser, Hassan Sardar Khan, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access

Tryptophan Metabolites in the Progression of Liver Diseases
M. S. Reshetova, Pavel A. Markin, Svetlana A. Appolonova, et al.
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1449-1449
Open Access

Unveiling cross-reactivity: implications for immune response modulation in cancer
Marco Antônio M. Pretti, Gustavo Fioravanti Vieira, Mariana Boroni, et al.
Briefings in Bioinformatics (2024) Vol. 26, Iss. 1
Open Access

Page 1

Scroll to top